X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Biopharmaceutical industry’s success reducing disparities for African Americans

By Myisha Gatson  |    February 16, 2017
February is Black History Month, and here at PhRMA, we continue our decades-long commitment to reducing disparities in health care for minorities through developing and helping communities access...   Read More

Medicare Monday: What is IPAB, and why is it bad for patients?

By Nicole Longo  |    February 13, 2017
In 2017, the Independent Payment Advisory Board (IPAB)couldfinally go into effect and come between patients and their health care providers. This week, we’re looking into this dangerous body.     Read More

4 things to think about when choosing your health plan

By Allyson Funk  |    October 28, 2016
Open enrollment is upon us once again. Whether you are picking a plan through your employer or a health insurance marketplace, whether you are getting coverage for the first time or changing to a...   Read More

New Spanish-language resources added to ABCs En Español

By Nicole Longo  |    October 13, 2016
With Hispanic Heritage Month coming to a close, we wanted to highlight two new videos that have been added to our Spanish-language resources microsite, AccessBetterCoverage.org/espanol.   Read More

4 recommendations for ICER

By Lauren Neves  |    September 26, 2016
For years, PhRMA has supported policies that ensure health care decisions are grounded in the best available evidence. In our policy solutions for delivering innovative treatments to patients...   Read More

New Survey: Patients’ share of health care costs continues to grow

By Allyson Funk  |    September 20, 2016
As we’ve highlighted before, a growing body of research continues to raise red flags about the implications of high cost sharing and patients’ ability to access affordable care – even if they have...   Read More

Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.

By Robert Zirkelbach  |    September 9, 2016
Despite recent headlines, U.S. spending on prescription medicines continues to decline. In fact, new data from Altarum Institute found that spending on prescription medicines grew by just 3.9...   Read More

Making drug formulary search tools better for patients

By Rebecca Davison  |    September 7, 2016
There is a real need for patients to have information about out-of-pocket costs and clinical tools being used when it comes to their coverage. A new prescription drug search tool that includes...   Read More

Empowering consumers and improving access to important clinical information

By Allyson Funk  |    August 29, 2016
Even though more Americans are insured than ever before, many are facing insurance barriers that may interfere with a doctor’s prescribed course of treatment and impact their care. We recently...   Read More

Medicare Monday: Concerns still abound about Part B proposal

By Allyson Funk  |    August 15, 2016
We’ve covered many of the concerns about the government’s overreaching proposal to change Medicare Part B payments and negatively impact seniors’ access to treatment. A lack of patient protections...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates